Hypersensitivity reactions related to oxaliplatin (OHP)
Open Access
- 29 July 2003
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 89 (3) , 477-481
- https://doi.org/10.1038/sj.bjc.6601155
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyAnnals of Oncology, 2002
- High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)European Journal Of Cancer, 2001
- Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)European Journal Of Cancer, 1999
- CorrespondenceEuropean Journal Of Cancer, 1998
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerPublished by Elsevier ,1997
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinomaEuropean Journal Of Cancer, 1994
- Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional TrialJNCI Journal of the National Cancer Institute, 1994
- Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateEuropean Journal Of Cancer, 1993
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancerCancer, 1992